These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24006958)

  • 1. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia.
    Shaboltas AV; Skochilov RV; Brown LB; Elharrar VN; Kozlov AP; Hoffman IF
    Harm Reduct J; 2013 Sep; 10():15. PubMed ID: 24006958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Lucas GM; Mullen BA; Weidle PJ; Hader S; McCaul ME; Moore RD
    Clin Infect Dis; 2006 Jun; 42(11):1628-35. PubMed ID: 16652321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
    Milloy MJ; Kerr T; Buxton J; Rhodes T; Krusi A; Guillemi S; Hogg R; Montaner J; Wood E
    J Acquir Immune Defic Syndr; 2012 Apr; 59(4):393-9. PubMed ID: 22134149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
    Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
    Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia.
    Idrisov B; Lunze K; Cheng DM; Blokhina E; Gnatienko N; Quinn E; Bridden C; Walley AY; Bryant KJ; Lioznov D; Krupitsky E; Samet JH
    Addict Sci Clin Pract; 2017 Dec; 12(1):30. PubMed ID: 29198185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia.
    Gnatienko N; Lioznov D; Raj A; Blokhina E; Rosen S; Cheng DM; Lunze K; Bendiks S; Truong V; Bushara N; Toussova O; Quinn E; Krupitsky E; Samet JH
    Addict Sci Clin Pract; 2020 Jan; 15(1):1. PubMed ID: 31931884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection drug use and HIV antiretroviral therapy discontinuation in a Canadian setting.
    Werb D; Milloy MJ; Kerr T; Zhang R; Montaner J; Wood E
    AIDS Behav; 2013 Jan; 17(1):68-73. PubMed ID: 22249956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users.
    Hadland SE; Milloy MJ; Kerr T; Zhang R; Guillemi S; Hogg RS; Montaner JS; Wood E
    AIDS Patient Care STDS; 2012 May; 26(5):274-80. PubMed ID: 22429003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
    Palepu A; Milloy MJ; Kerr T; Zhang R; Wood E
    J Urban Health; 2011 Jun; 88(3):545-55. PubMed ID: 21409604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
    Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
    Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
    May MT; Justice AC; Birnie K; Ingle SM; Smit C; Smith C; Neau D; Guiguet M; Schwarze-Zander C; Moreno S; Guest JL; Monforte Ad; Tural C; Gill MJ; Bregenzer A; Kirk O; Saag M; Sterling TR; Crane HM; Sterne JA
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):348-54. PubMed ID: 25848927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.